The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease
Open accessAbstract
BACKGROUND: Restricting protein intake and controlling hypertension delay the progression of renal disease in animals. We tested these interventions in 840 patients with various chronic renal diseases. METHODS: In study 1, 585 patients with glomerular filtration rates of 25 to 55 ml per minute per 1.73 m2 of body-surface area were randomly assigned to a usual-protein diet or a low-protein diet (1.3 or 0.58 g of protein per kilogram of body weight per day) and to a usual- or a low-blood-pressure group (mean arterial pressure, 107 or 92 mm Hg). In study 2, 255 patients with glomerular filtration rates of 13 to 24 ml per minute per 1.73 m2 were randomly assigned to the low-protein diet (0.58 g per kilogram per day) or a very-low-protein diet (0.28 g per kilogram per day) with a keto acid-amino acid supplement, and a usual- or a low-blood-pressure group (same values as those in study 1). An 18-to-45-month follow-up was planned, with monthly evaluations of the patients. RESULTS: The mean follow-up was 2.2 years. In study 1, the projected mean decline in the glomerular filtration rate at three years did not differ significantly between the diet groups or between the blood-pressure groups. As compared with the usual-protein group and the usual-blood-pressure group, the low-protein group and the low-blood-pressure group had a more rapid decline in the glomerular filtration rate during the first four months after randomization and a slower decline thereafter. In study 2, the very-low-protein group had a marginally slower decline in the glomerular filtration rate than did the low-protein group (P = 0.07). There was no delay in the time to the occurrence of end-stage renal disease or death. In both studies, patients in the low-blood-pressure group who had more pronounced proteinuria at base line had a significantly slower rate of decline in the glomerular filtration rate. CONCLUSIONS: Among patients with moderate renal insufficiency, the slower decline in renal function that started four months after the introduction of a low-protein diet suggests a small benefit of this dietary intervention. Among patients with more severe renal insufficiency, a very-low-protein diet, as compared with a low-protein diet, did not significantly slow the progression of renal disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Compared with a noneproteinlimited diet, a low-protein diet of 0.6 g/kg BW/d can prevent a decline in GFR of approximately 1 mL/min per year per 1.73 m 2 and is associated with a 30% decrease in reaching a dialysisdependent stage.114,115”
From Evidence-Based Recommendations for Optimal Dietary Protein Intake in Older People: A Position Paper From the PROT-AGE Study Group (2013) · cites this paper as [115]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Reducing the amount of dietary protein below the recommended daily allowance of 0.8 g/kg/day is not recommended because it does not alter blood glucose levels, cardiovascular risk measures, or the course of GFR decline (46).”
From 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [46]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In people with CKD and diabetes, consuming protein below the recommended daily allowance of 0.8 g/kg/day is not recommended, because it does not alter blood glucose levels, cardiovascular risk measures, or the course of GFR decline (48).”
From 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2026 (2026) · cites this paper as [48]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Under those conditions, the development of malnutrition during a low-protein diet is an extremely rare event.115”
From Evidence-Based Recommendations for Optimal Dietary Protein Intake in Older People: A Position Paper From the PROT-AGE Study Group (2013) · cites this paper as [115]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer series in statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,239
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Random-Effects Models for Longitudinal Data
Laird, N. M., & Ware, J. H. (1982) · Biometrics · doi:10.2307/2529876 · Cited by 8,923
(1993) · Archives of Internal Medicine · doi:10.1001/archinte.1993.00410020010002 · Cited by 1,974
Anthropometric standards for the assessment of growth and nutritional status
(1991) · Clinical Nutrition · doi:10.1016/0261-5614(91)90103-j · Cited by 1,197
The modification of diet in renal disease study group
Beck, G. J., Berg, R. L., Coggins, C. H., Gassman, J., Hunsicker, L. G., SCHLUCHTER, M. D., & Williams, G. W. (1991) · Controlled Clinical Trials · doi:10.1016/0197-2456(91)90069-x · Cited by 818
Self-citationA method for estimating nitrogen intake of patients with chronic renal failure
Maroni, B. J., Steinman, T. I., & Mitch, W. E. (1985) · Kidney International · doi:10.1038/ki.1985.10 · Cited by 789
Hemodynamically mediated glomerular injury and the progressive nature of kidney disease
Brenner, P. D. B. M. (1983) · Kidney International · doi:10.1038/ki.1983.72 · Cited by 617
PROSPECTIVE RANDOMISED TRIAL OF EARLY DIETARY PROTEIN RESTRICTION IN CHRONIC RENAL FAILURE
Rosman, J. B., ter Wee, P. M., Truus, S. M., Piers-Becht, P. M., Sluiter, W., & Donker, A. M. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90818-3 · Cited by 554
The Modification of Diet in Renal Disease Study
Klahr, S. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903303201310 · Cited by 454
Self-citation
Research works printed but not linked: 6
- Hunsicker LG, 1989, Semin Nephrol, 9, 380
- 10.1001/archinte.153.2.154 · DOI
- Levey AS, 1989, Kidney Int Suppl, 27, S
- Kopple JD, 1989, Kidney Int Suppl, 27, S
- Greene T, 1993, J Am Soc Nephrol, 3, 1819
- 10.2307/2281868 · DOI · Paper page
Cited by
Sorted by citations
Items 901–1,000 of 1,000
Uncontrolled hypertension by the 2014 evidence-based guideline
Sakhuja, A., Textor, S. C., & Taler, S. J. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000442 · Cited by 26
Beasley, J. M., Aragaki, A. K., LaCroix, A. Z., Neuhouser, M. L., Tinker, L. F., Cauley, J. A., Ensrud, K. E., Jackson, R. D., & Prentice, R. L. (2011) · The Journal of Nutrition · doi:10.3945/jn.110.135814 · Cited by 26
SPRINT Revisited: Updated Results and Implications
Wright, J. T., Whelton, P. K., Johnson, K., Snyder, J. K., Reboussin, D. M., Cushman, W. C., Williamson, J. D., Pajewski, N. M., Cheung, A. K., Lewis, C. E., et al. (2021) · Hypertension · doi:10.1161/hypertensionaha.121.17682 · Cited by 28
Bansal, G. J., & Darby, M. J. (2009) · Journal of Computer Assisted Tomography · doi:10.1097/rct.0b013e31818160a3 · Cited by 26
A role for single-pill triple therapy in hypertension
Elijovich, F., & Laffer, C. L. (2009) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944709334947 · Cited by 26
Effects of angiotensin II receptor blockers on diabetic nephropathy
Kalaitzidis, R., & Bakris, G. L. (2009) · Journal of Hypertension · doi:10.1097/01.hjh.0000357904.71080.7d · Cited by 26
Franch, H. A., & Mitch, W. E. (2009) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-080508-141051 · Cited by 26
Beyond Sodium, Phosphate and Potassium: Potential Dietary Interventions in Kidney Disease
Kelly, J. T., Rossi, M., Johnson, D. W., & Campbell, K. L. (2017) · Seminars in Dialysis · doi:10.1111/sdi.12580 · Cited by 26
Agarwal, R. (2007) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e3282063b86 · Cited by 26
Lifestyle modification and progressive renal failure
Ritz, E., & Schwenger, V. (2005) · Nephrology · doi:10.1111/j.1440-1797.2005.00439.x · Cited by 26
Sandstede, J. J. W., Roth, A. C., Machann, W., Kaupert, C., & Hahn, D. (2007) · European Journal of Radiology · doi:10.1016/j.ejrad.2007.01.021 · Cited by 26
Calcium Channel Antagonists in the Treatment of Hypertension
Weber, M. A. (2002) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200202060-00006 · Cited by 26
Malnutrition-inflammation-atherosclerosis syndrome in Chronic Kidney disease
Rao, P., Reddy, G. C., & Kanagasabapathy, A. S. (2008) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-008-0048-9 · Cited by 26
Friedman, E. A. (1996) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70326-1 · Cited by 26
Darche, F. F., Baumgärtner, C., Biener, M., Müller‐Hennessen, M., Vafaie, M., Koch, V., Stoyanov, K. M., Rivinius, R., Katus, H. A., & Giannitsis, E. (2017) · ESC Heart Failure · doi:10.1002/ehf2.12150 · Cited by 25
Petersen, K. S., Kris‐Etherton, P. M., McCabe, G. P., Raman, G., Miller, J. W., & Maki, K. C. (2021) · Advances in Nutrition · doi:10.1093/advances/nmab045 · Cited by 26
Prediction of renal insufficiency in Pima Indians with nephropathy of type 2 diabetes mellitus
Goldfarb‐Rumyantzev, A. S., & Pappas, L. M. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.34503 · Cited by 25
Role of Adipose Tissue in Determining Muscle Mass in Patients With Chronic Kidney Disease
Castaneda‐Sceppa, C., Sarnak, M. J., Wang, X., Greene, T., Madero, M., Kusek, J. W., Beck, G. J., Kopple, J. D., Levey, A. S., & Menon, V. (2007) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2007.05.006 · Cited by 25
Self-citationTent, H., Lely, A. T., Toering, T. J., Giorgi, M., Rook, M., Lems, S. P. M., Hepkema, B. G., Hofker, H. S., Ploeg, R. J., van der Heide, J. J. H., et al. (2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03687.x · Cited by 25
Renal involvement in Fabry disease
Abensur, H., & dos Reis, M. A. (2016) · Brazilian Journal of Nephrology · doi:10.5935/0101-2800.20160034 · Cited by 25
Urinary albumin excretion: a predictor of glomerular findings in adults with microscopic haematuria
Eardley, K. S., Ferreira, M. A. S., Howie, A. J., Gosling, P. J., & Lipkin, G. W. (2004) · QJM · doi:10.1093/qjmed/hch049 · Cited by 25
Nephroprotective effect of antihypertensive drugs in essential hypertension
Sušić, D., & Frohlich, E. D. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816050-00001 · Cited by 25
Management of hypertension in patients developing end-stage renal failure
Dasgupta, I., Madeley, R. J., Pringle, M. A. L., Savill, J., & BURDEN, R. P. (1999) · QJM · doi:10.1093/qjmed/92.9.519 · Cited by 25
Renoprotective effects of antihypertensive drugs
Preston, R. A. (1999) · American Journal of Hypertension · doi:10.1016/s0895-7061(98)00210-6 · Cited by 25
Striker, G. (1995) · Journal of the American Society of Nephrology · doi:10.1681/asn.v571537 · Cited by 25
Self-citationCrook, E. D., Harris, J., Oliver, B. L., Fleischmann, E. H., Crenshaw, G. D., & Taylor, R. T. (2001) · Journal of Investigative Medicine · doi:10.2310/6650.2001.33974 · Cited by 25
Elucidating the complex interplay between chronic kidney disease and hypertension
Nagata, D., & Hishida, E. (2024) · Hypertension Research · doi:10.1038/s41440-024-01937-8 · Cited by 27
Inhibition of the renin–angiotensin system and chronic kidney disease
Siamopoulos, K. C., & Kalaitzidis, R. (2008) · International Urology and Nephrology · doi:10.1007/s11255-008-9424-x · Cited by 24
Polzin, D. J., & Churchill, J. A. (2016) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2016.06.005 · Cited by 24
ASIAN PACIFIC SOCIETY OF NEPHROLOGY CLINICAL PRACTICE GUIDELINE ON DIABETIC KIDNEY DISEASE
Liew, A., Bavanandan, S., Prasad, N., Wong, M. G., Chang, J. M., Eiam‐Ong, S., Hao, C., Lim, C. Y., Lim, S. K., Oh, K., et al. (2020) · Nephrology · doi:10.1111/nep.13785 · Cited by 24
Yan, P., Zhu, X., Li, H., Shrubsole, M. J., Shi, H., Zhang, M., Harris, R. C., Hao, C., & Dai, Q. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037837 · Cited by 24
Optimising the accuracy of blood pressure monitoring in chronic kidney disease: the utility of BpTRU
Brothwell, S., Dutton, M., Ferro, C. J., Stringer, S. J., & Cockwell, P. (2013) · BMC Nephrology · doi:10.1186/1471-2369-14-218 · Cited by 23
Wenzel, U. O., Hebert, L. A., Stahl, R. A. K., & Krenz, I. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01140905 · Cited by 24
on behalf of CKD-REIN study investigators, Affret, A., Wagner, S., Fatouhi, D. E., Dow, C., Correia, E., Niravong, M., Clavel‐Chapelon, F., Chefdebien, J., Fouque, D. P., et al. (2017) · BMC Nephrology · doi:10.1186/s12882-017-0695-2 · Cited by 24
Joint Analysis of Longitudinal Data with Informative Right Censoring
Liu, M., & Ying, Z. (2007) · Biometrics · doi:10.1111/j.1541-0420.2007.00708.x · Cited by 24
Current Strategies for Management of Hypertensive Renal Disease
Moore, M. A., Epstein, M., Agodoa, L. Y. C., & Dworkin, L. D. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.1.23 · Cited by 24
Pharmacologic management of diabetic nephropathy
Vivian, E., & Rubinstein, G. B. (2002) · Clinical Therapeutics · doi:10.1016/s0149-2918(02)80076-5 · Cited by 24
Progression of renal failure and hypertensive nephrosclerosis
Zucchelli, P. C., & Zuccalà, A. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.06814.x · Cited by 24
Etiology and Management of Hypertension in Chronic Kidney Disease
Andersen, M. J., & Agarwal, R. (2005) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.12.001 · Cited by 24
What is normal blood pressure?
Freitag, M., & Vasan, R. S. (2003) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200305000-00010 · Cited by 24
Complications of chronic renal insufficiency: Beyond cardiovascular disease
Zabetakis, P. M., & Nissenson, A. R. (2000) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2000.19929 · Cited by 24
Effects of Antihypertensive Drugs on Renal Function in Patients With Diabetic Nephropathy
Bretzel, R. G. (1997) · American Journal of Hypertension · doi:10.1016/s0895-7061(97)00155-6 · Cited by 24
Aldosterone antagonists for preventing the progression of chronic kidney disease
Navaneethan, S. D., Nigwekar, S. U., Sehgal, A. R., & Strippoli, G. F. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007004.pub2 · Cited by 24
Kazama, I., Maruyama, Y., Endo, Y., Toyama, H., Ejima, Y., Matsubara, M., & Kurosawa, S. (2012) · International Journal of Nephrology · doi:10.1155/2012/581581 · Cited by 23
Pharmacologic inhibition of intestinal sodium uptake
Spencer, A. G., & Greasley, P. J. (2015) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000154 · Cited by 24
High-protein diet accelerates diabetes and kidney disease in the BTBRob/ob mouse
Granqvist, A., Ericsson, A., Sánchez, J., Tonelius, P., William‐Olsson, L., Dahlqvist, U., Andersson, A., Tomić, T. T., Hudkins, K. L., Alpers, C. E., et al. (2020) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00484.2019 · Cited by 23
Protein intake and renal function in older patients
Narasaki, Y., Rhee, C. M., Kramer, H., & Kalantar‐Zadeh, K. (2020) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000712 · Cited by 23
Protein Restriction for CKD: Time to Move On
Obeid, W., Hiremath, S., & Topf, J. (2022) · Kidney360 · doi:10.34067/kid.0001002022 · Cited by 23
Gut-kidney axis in IgA nephropathy: Role on mesangial cell metabolism and inflammation
Luvizotto, M. J., Menezes-Silva, L., Woronik, V., Monteiro, R. C., & Câmara, N. O. S. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.993716 · Cited by 22
Protein Carbamylation and the Risk of ESKD in Patients with CKD
Kalim, S., Zhao, S. J., Tang, M., Rhee, E. P., Allegretti, A. S., Nigwekar, S. U., Karumanchi, S. A., Lash, J. P., & Berg, A. H. (2023) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000000000078 · Cited by 26
White, C. A., & Akbari, A. (2011) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2011.00943.x · Cited by 23
Arefhosseini, S. R., Ebrahimi‐Mameghani, M., Farsad-Naeimi, A., Khoshbaten, M., & rashid, J. (2011) · Europe PMC (PubMed Central) · doi:10.5681/hpp.2011.016 · Cited by 24
Cheng, I. K. P., FANG, G., WONG, M., JI, Y., Chan, K., & YEUNG, H. W. D. (1998) · Nephrology · doi:10.1046/j.1440-1797.1998.d01-12.x · Cited by 23
Proteinuria Thresholds Are Irrational: A Call for Proteinuria Indexing
Ellam, T., & Nahas, M. E. (2010) · Nephron Clinical Practice · doi:10.1159/000321687 · Cited by 23
Nutritional treatment in chronic kidney disease: the concept of nephroprotection
Riccio, E., Nuzzi, A. D., & Pisani, A. (2014) · Clinical and Experimental Nephrology · doi:10.1007/s10157-014-1041-7 · Cited by 23
Predictive factors of progression of chronic renal insufficiency: a multivariate analysis
Soares, C. M. B., OLIVEIRA, E. A., Diniz, J. S. S., Lima, E. M., Vasconcelos, M. M. D. A., & Oliveira, G. R. (2003) · Pediatric Nephrology · doi:10.1007/s00467-003-1115-3 · Cited by 23
Preston, R. A., Baltodano, N. M., Alonso, A. B., & Epstein, M. (2002) · The Journal of Clinical Pharmacology · doi:10.1177/009127002401102696 · Cited by 23
Are Observational Studies ‘Just as Effective’ as Randomized Clinical Trials?
Greene, T. (2000) · Blood Purification · doi:10.1159/000014455 · Cited by 23
Imai, E., Ito, S., Haneda, M., Harada, A., Kobayashi, F., Yamasaki, T., Makino, H., & Chan, J. C. N. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv272 · Cited by 22
Childhood course of renal insufficiency in a family with a uromodulin gene mutation
Schäffer, P., Gombos, É., Meichelbeck, K., Kiss, A., Hart, P. S., & Bleyer, A. J. (2010) · Pediatric Nephrology · doi:10.1007/s00467-009-1436-y · Cited by 22
Guebre‐Egziabher, F., Brunelle, C., Jouvé, T., Pelletier, C. C., Normand, G., Juillard, L., Dubourg, L. D., & Lemoine, S. (2019) · Obesity · doi:10.1002/oby.22574 · Cited by 23
Torreggiani, M., Fois, A., Lippi, F., Attini, R., Longhitano, E., Matarazzo, I., Masturzo, B., Cabiddu, G., Versino, E., & Piccoli, G. B. (2022) · Clinical Kidney Journal · doi:10.1093/ckj/sfac267 · Cited by 23
Referral and Comanagement of the Patient With CKD
Campbell, G. A., & Bolton, W. K. (2011) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2011.10.006 · Cited by 22
Management of hypertension with fixed-dose triple-combination treatments
Epstein, B. J., Shah, N. K., & Borja‐Hart, N. (2013) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944713498638 · Cited by 22
Rabito, C. A., Halpern, E. F., Scott, J., & TOLKOFF-RUBIN, N. E. (2010) · Transplantation · doi:10.1097/tp.0b013e3181e9139d · Cited by 22
the PREPARE-1 study group, de Goeij, M. C. M., Voormolen, N., Halbesma, N., de Jager, D. J., Boeschoten, E. W., Sijpkens, Y. W. J., Dekker, F. W., & Grootendorst, D. C. (2011) · BMC Nephrology · doi:10.1186/1471-2369-12-38 · Cited by 22
Role of dietary phosphate restriction in chronic kidney disease
Elder, G. J., Malik, A., & Lambert, K. (2017) · Nephrology · doi:10.1111/nep.13188 · Cited by 22
Vettoretti, S., Caldiroli, L., Zanoni, F., Azzini, V., Villarini, A., Meazza, R., & Messa, P. (2018) · Kidney & Blood Pressure Research · doi:10.1159/000495388 · Cited by 22
The low-protein diet for chronic kidney disease: 8 years of clinical experience in a nephrology ward
Baragetti, I., Simone, I. D., Biazzi, C., Buzzi, L., Ferrario, F., Luise, M. C., Santagostino, G., Furiani, S., Alberghini, E., Capitanio, C., et al. (2019) · Clinical Kidney Journal · doi:10.1093/ckj/sfz141 · Cited by 25
Hypertension in Chronic Kidney Disease
Schaefer, F. S. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-824-9_22 · Cited by 22
Negative trials in nephrology: what can we learn?
Novak, J. E., Inrig, J. K., Patel, U. D., Califf, R. M., & Szczech, L. A. M. (2008) · Kidney International · doi:10.1038/ki.2008.286 · Cited by 22
Beverages, diet, and prevention of kidney stones
Goldfarb, D. S., & Coe, F. L. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70319-7 · Cited by 22
Chiang, H.-P., Lee, J., Chiu, Y., Tsai, J., Hung, C., Hwang, S., & Chen, H. (2014) · American Journal of Hypertension · doi:10.1093/ajh/hpu056 · Cited by 22
Can we slow the progression of chronic kidney disease?
Wühl, E., & Schaefer, F. S. (2010) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e3283360a5c · Cited by 21
ACE inhibitors and proteinuria
Gansevoort, R. T., de Zeeuw, D., & de Jong, P. E. (1996) · Pharmacy World & Science · doi:10.1007/bf00735961 · Cited by 22
Outcome studies in diabetic nephropathy
Mohanram, A., & Toto, R. D. (2003) · Seminars in Nephrology · doi:10.1016/s0270-9295(03)00061-5 · Cited by 22
Blood pressure control, proteinuria and renal outcome in chronic renal failure
Ruilope, L. M., Campo, C., & Rodicio, J. L. (1998) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-199803000-00001 · Cited by 22
Conservative treatment to slow deterioration of renal function: Evidence-based recommendations
Burgess, E. D. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.07003.x · Cited by 22
A Practical Approach to the Management of Patients With Chronic Renal Failure
McCarthy, J. T. (1999) · Mayo Clinic Proceedings · doi:10.4065/74.3.269 · Cited by 22
Schmieder, R. E. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000166826.17570.86 · Cited by 22
Weir, M. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.11.017 · Cited by 23
Kidney Failure Stabilizes after a Two-Decade Increase
Ruggenenti, P. L., & Remuzzi, G. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02830806 · Cited by 22
Drexler, Y. R., & Bomback, A. S. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft346 · Cited by 21
Effects of Intensive Blood Pressure Control in Patients with and without Albuminuria
Chang, A. R., Kramer, H., Wei, G., Boucher, R. E., Grams, M. E., Berlowitz, D. R., Bhatt, U. Y., Cohen, D. L., Drawz, P. E., Punzi, H. A., et al. (2020) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.12371019 · Cited by 21
Thanachayanont, T., Chanpitakkul, M., Hengtrakulvenit, J., Watcharakanon, P., Wisansak, W., Tancharoensukjit, T., Kaewsringam, P., Leesmidt, V., Pongpirul, K., Lekagul, S., et al. (2021) · Nephrology · doi:10.1111/nep.13849 · Cited by 21
Lee, H., Lee, H., Townsend, R. R., Kim, D. W., Park, S., & Kim, H. C. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.02.040 · Cited by 23
Luciano, E. D. P., Luconi, P. S., Sesso, R., Melaragno, C. S., Abreu, P. F., Reis, S. F. S., Furtado, R. M. S., & Ruivo, G. F. (2012) · Brazilian Journal of Nephrology · doi:10.5935/0101-2800.20120003 · Cited by 21
Bloomfield, G. S., Yi, S. S., Astor, B. C., Kramer, H., Shea, S., Shlipak, M. G., & Post, W. S. (2013) · Journal of Human Hypertension · doi:10.1038/jhh.2013.1 · Cited by 21
Light and shadows of dietary protein restriction in elderly with Chronic Kidney Disease
Giordano, M., Ciarambino, T., Castellino, P., & Paolisso, G. (2013) · Nutrition · doi:10.1016/j.nut.2013.01.023 · Cited by 21
Kuijvenhoven, M. A., Haak, E. A. F., Handoko, K. B., & Crul, M. (2013) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-013-9830-8 · Cited by 21
Defining, Treating, and Understanding Chronic Kidney Disease—A Complex Disorder
Campbell, D., & Weir, M. R. (2015) · Journal of Clinical Hypertension · doi:10.1111/jch.12560 · Cited by 21
Hirano, K., Amano, H., Kawamura, T., Watanabe, K., Koike, K., Shimizu, A., Endo, S., Tsuboi, N., Okonogi, H., Miyazaki, Y., et al. (2015) · Clinical and Experimental Nephrology · doi:10.1007/s10157-015-1170-7 · Cited by 21
Introduction to Glomerular Disease
Floege, J., & Feehally, J. (2010) · Elsevier eBooks · doi:10.1016/b978-0-323-05876-6.00015-0 · Cited by 21
Li, Y., Liang, M., Jiang, C., Wang, G., Li, J., Zhang, Y., Fan, F., Sun, N., Cui, Y., He, M., et al. (2017) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfx267 · Cited by 21
Antihypertensive treatment and renal protection: Is there a J‐curve relationship?
Viazzi, F. C., Leoncini, G., Grassi, G. M., & Pontremoli, R. (2018) · Journal of Clinical Hypertension · doi:10.1111/jch.13396 · Cited by 20
Diagnosis Patterns of CKD and Anemia in the Japanese Population
Kimura, T., Snijder, R. J., & Nozaki, K. (2020) · Kidney International Reports · doi:10.1016/j.ekir.2020.03.006 · Cited by 22
Chapter 3: Blood pressure management in CKD ND patients without diabetes mellitus
(2012) · Kidney International Supplements · doi:10.1038/kisup.2012.53 · Cited by 21
Pathogenesis of Tubular Interstitial Nephritis
Tanaka, T., & Nangaku, M. (2011) · Contributions to nephrology · doi:10.1159/000314577 · Cited by 20
Stefanović, V., & Milojković, M. (2005) · The International Journal of Artificial Organs · doi:10.1177/039139880502800103 · Cited by 21
(2022) · PubMed Central · doi:10.6515/acs.202205_38(3).20220321a · Cited by 117
Metadata
- Authors
- Klahr, S., Levey, A. S., Beck, G. J., Caggiula, A. W., Hunsicker, L., Kusek, J. W., & Striker, G.
- Affiliations
- National Institutes of Health (US)
- Tufts Medical Center (US)
- Cleveland Clinic (US)
- University of Pittsburgh (US)
- University of Iowa Hospitals and Clinics (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1994-03-31
- Volume
- 330
- Issue
- 13
- Pages
- 877-884
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2321986725
- Semantic Scholar
- 01e2c22d0073b85c7e2ba3a9327f2c898329d6af
- Cited by
- 2,328
- References
- 30
- Citations by year
- 2026: 25 · 2025: 53 · 2024: 56 · 2023: 66 · 2022: 64 · 2021: 74 · 2020: 73 · 2019: 82 · 2018: 81 · 2017: 98 · 2016: 82 · 2015: 84 · 2014: 100 · 2013: 92 · 2012: 92
- FWCI
- 51.46
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Keywords
- chronic kidney disease, protein restriction, very low protein diet, low-protein diet, blood pressure control, hypertension, glomerular filtration rate decline, end-stage renal disease, proteinuria, renal failure, disease progression, mortality, renal function decline, end-stage renal disease prevention, mortality prevention
- MeSH terms
- Blood Pressure, Chronic Disease, Dietary Proteins, Female, Follow-Up Studies, Glomerular Filtration Rate, Humans, Hypertension, Kidney Diseases, Kidney Failure, Chronic, Polycystic Kidney Diseases, Male, Middle Aged, Linear Models
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review